This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ICAD Showcases Its Computer-Aided Detection And Advanced Image Analysis Solutions At RSNA 2011

Stocks in this article: ICAD

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, will showcase its family of computer-aided detection (CAD) and advanced imaging solutions at the Radiological Society of North America (RSNA) Annual Meeting this week in Chicago, Ill. Specifically, iCAD will highlight the latest version of its magnetic resonance imaging (MRI) product suite which includes a new MRI-guided prostate biopsy prototype, as well as an integrated MR/TRUS-FUSION work-in-progress solution. In addition, iCAD’s VeraLook CT CAD technology will be demonstrated with Vital Images Vitrea workstation for the first time since the combined solution was made available earlier this year.

“In 2011, we have made significant progress in our advanced image analysis and CAD product lines,” said Ken Ferry, President and CEO of iCAD. “With solutions that address new markets including prostate cancer and colon cancer, we are encouraged that more clinicians and patients will be able to realize the benefits of our CAD and image analysis innovation.”

At iCAD’s RSNA booth #811 in Hall D, the company will be showcasing:

  • iCAD’s full MRI product suite, which includes VividLook®, SpectraLook®, OmniLook®, PrecisionPoint® and VersaVue® Enterprise version 3.1.1.
  • iCAD’s next-generation CAD solution for mammography, SecondLook Premier*, as well as its SecondLook Digital Multi-Vendor solution.
  • iCAD’s VeraLook CTC CAD solution, demonstrated on a Vital Images Vitrea, TeraRecon AQI, and Viatronix V3D workstations.

iCAD will also be displaying several works-in-progress, including:

  • A new MRI-guided prostate biopsy prototype solution that features a combination probe and positioning software to create a more productive method of targeting and scanning areas of interest, and a faster, more comfortable experience for the patient.
  • New prostate MRI/TRUS-Fusion technology that will allow radiologists and urologists to provide a more accurate assessment of the prostate gland and increase the accuracy of TRUS biopsies by better localizing the area of concern through fusing MRI and Ultrasound images.

iCAD will also co-present two educational exhibit sessions:

In addition, iCAD will present a co-authored scientific poster entitled “MRI Brain DCE and DSC Characteristics in a Novel Chemotherapy Using Neural Stem Cells in Patients with Recurrent High-Grade Glioma: Initial Results and Work in Progress.”

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs